Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Vaccines, Blood & Biologics

?

-

Resources for You

Public Workshop - Data and Data Needs to Advance Risk Assessment for Emerging Infectious Diseases Relevant to Blood and Blood Products

-

Public Workshop - Data and Data Needs to Advance Risk Assessment for Emerging Infectious Diseases Relevant to Blood and Blood Products: Presentations

-

FDA Presentations

Use of Quantitative Risk Assessments in Blood Safety Regulation (PPT - 81KB)
Jay S. Epstein, M.D.
Questionnaire Data for Risk Assessment (PPT - 428KB)
Richard Forshee
Overview of Quantitative Risk Assessment Process and Data Needs (PPT - 86KB)
Mark Walderhaug
“Exercise Only” Emerging Infection Scenario, Morning Session (PPT - 93KB)
“Exercise Only” Emerging Infection Scenario, Afternoon Session (PPT - 93KB)
Disease Prevalence Data for Risk Assessment (PPT - 2MB)
Lou Gallagher, PhD
Data Needed and Examples of Application in FDA Risk Assessments of Emerging Transfusion-Transmitted Diseases (PPT - 644KB)
Hong Yang, Ph.D.

-

-

Other Presentations

Red Cross Presenters at FDA Public Workshop

-

-

-